Understanding the Relationships of Cardiac Diagnostics in Patients with Amyloid Transthyretin Cardiac Amyloidosis

Amyloid transthyretin (ATTR) cardiac amyloidosis (CA) is an increasingly recognized cause of restrictive cardiomyopathy and associated heart failure with preserved ejection fraction (HFpEF). Despite improved diagnostic techniques to identify this condition, many patients experience delayed diagnosis. Interpretation of routine cardiac biomarkers (i.e. troponins and brain natriuretic peptide (BNP)) and echocardiography in ATTR-CA is limited, particularly in relation to pyrophosphate (PYP) scintigraphy.

Source: The Journal of Heart and Lung Transplantation - March 31, 2020 Category: Transplant Surgery Authors: B. Di Giovanni, D. Gustafson, M.B. Adamson, K. Runeckles, D.H. Delgado Tags: (64) Source Type: research